Mirum Pharmaceuticals (MIRM) Q2 2024 Earnings

8MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.94
-1.37
-0.81
-0.24

Details

Expected EPS
-0.420267
Actual EPS
-0.54
Surprise EPS
-0.12
Surprise Percent
+28.49%

Description

Mirum Pharmaceuticals (MIRM) has reported earnings of -0.54 per share for Q2 2024.

0 Comments

Share your thoughts